MRNA vs. JNJ
Compare and contrast key facts about Moderna, Inc. (MRNA) and Johnson & Johnson (JNJ).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: MRNA or JNJ.
Correlation
The correlation between MRNA and JNJ is 0.16, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
MRNA vs. JNJ - Performance Comparison
Key characteristics
MRNA:
-1.11
JNJ:
0.13
MRNA:
-2.21
JNJ:
0.31
MRNA:
0.73
JNJ:
1.04
MRNA:
-0.79
JNJ:
0.14
MRNA:
-1.28
JNJ:
0.43
MRNA:
58.87%
JNJ:
5.94%
MRNA:
67.86%
JNJ:
18.88%
MRNA:
-94.82%
JNJ:
-52.60%
MRNA:
-94.82%
JNJ:
-9.99%
Fundamentals
MRNA:
$9.71B
JNJ:
$369.29B
MRNA:
-$9.28
JNJ:
$5.79
MRNA:
0.00
JNJ:
1.09
MRNA:
$3.06B
JNJ:
$67.44B
MRNA:
$1.65B
JNJ:
$46.48B
MRNA:
-$2.27B
JNJ:
$19.10B
Returns By Period
In the year-to-date period, MRNA achieves a -39.61% return, which is significantly lower than JNJ's 6.81% return.
MRNA
-39.61%
-28.69%
-58.29%
-75.45%
-6.35%
N/A
JNJ
6.81%
-7.19%
-2.86%
3.71%
5.63%
7.30%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
MRNA vs. JNJ — Risk-Adjusted Performance Rank
MRNA
JNJ
MRNA vs. JNJ - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Moderna, Inc. (MRNA) and Johnson & Johnson (JNJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
MRNA vs. JNJ - Dividend Comparison
MRNA has not paid dividends to shareholders, while JNJ's dividend yield for the trailing twelve months is around 3.24%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MRNA Moderna, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
JNJ Johnson & Johnson | 3.24% | 3.40% | 3.00% | 2.52% | 2.45% | 2.53% | 2.57% | 2.74% | 2.38% | 2.73% | 2.87% | 2.64% |
Drawdowns
MRNA vs. JNJ - Drawdown Comparison
The maximum MRNA drawdown since its inception was -94.82%, which is greater than JNJ's maximum drawdown of -52.60%. Use the drawdown chart below to compare losses from any high point for MRNA and JNJ. For additional features, visit the drawdowns tool.
Volatility
MRNA vs. JNJ - Volatility Comparison
Moderna, Inc. (MRNA) has a higher volatility of 17.82% compared to Johnson & Johnson (JNJ) at 10.16%. This indicates that MRNA's price experiences larger fluctuations and is considered to be riskier than JNJ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
MRNA vs. JNJ - Financials Comparison
This section allows you to compare key financial metrics between Moderna, Inc. and Johnson & Johnson. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities